Delivery Order SPE2DB20D9127-SPE2DB25FPRE9
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Jakafi 15 mg tablets (60-count units) with a ceiling value of $11,999.80. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and was awarded on August 1, 2025. This award utilizes no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 31, 2025, by the Defense Logistics Agency for the supply of Jakafi 10 mg tablets (60-count unit). This firm fixed-price delivery order, valued at $24,231.30, represents a single shipment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The contract includes no set-aside designation, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order, valued at $36,115.27, represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total value of $500...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total contract value of $499,999,999 through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 28, 2025, by the Defense Logistics Agency (DLA) for the supply of Jakafi 15 mg tablets (60 count). This $24.0K firm fixed-price delivery order, which was completed on July 29, 2025, carries no set-aside designation and represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 21, 2025, for the supply of Jakafi 20 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,089.78, represents a single line-item procurement without a set-aside designation, with an ultimate completion date of August 22, 2025. The award was issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12.0K on July 22, 2025, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), the Department of Defense's combat support agency responsible for logistics and supply chain management. The award carries an ultimate completion date of July 23, 2025, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,146.79 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Jakafi 5 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis leveraging its established...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,231.30 for 60 tablets of Jakafi 10 mg on September 19, 2025. The contract carries an ultimate completion date of September 22, 2025 and was issued without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48.6K on August 14, 2025, for the supply of Jakafi 5 mg tablets (60-count units) to support federal medical supply needs. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents execution under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRE9Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Jakafi 10 mg tablets (60-count units) with a ceiling value of $24,231.30. The contract, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group's role as a pharmaceutical wholesaler positions it as a critical supplier within the federal pharmaceutical supply chain, delivering prescription medications and pharmacy services directly to Department of Defense healthcare sites. Jakafi (ruxolitinib), an oral medication used for certain myeloproliferative disorders, represents the type of specialized pharmaceutical product the company regularly supplies through its established relationship with the DLA. The tight completion timeline indicates this delivery order fulfills an urgent operational need for the Defense Logistics Agency's medical supply distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.2k | 8/21/25 |